Lifestyle Delivery Systems Inc. Announces Delivery Service for CannaStripsTM and Rêveur in Coachella Valley
Vancouver, British Columbia, Canada, April 19, 2018, Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces delivery service of CannaStripsTM and Rêveur products in the Coachella Valley.
TheCannaStripsTM andRêveurproductlineswillbeavailablefordeliverythrough Kannabisworks.com. Kannabis Works will have a pop up at Base Camp during Indio, CA festival weekend events. You can follow the weekend highlights and interviews on social media at @_cannastrips and @lereveuressentials.
CannaStripsTM and Rêveur are hosting events at the Base Camp pool April 20 – 22, 2018. Pitchfork Radio, presented by Verizon, will be broadcasting live from Base Camp through the weekend with artist appearances, interviews and mixes available at Pitchfork.com. For more information about Rêveur at Base Camp, contact VIP@reveurbrands.com.
About Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. is a licensed, state-compliant vertically integrated cannabis-related company. From our isogenic pollination nursery to our cutting edge, state-of-the-art production facility located in Southern California, LDS has become one of the most diverse, innovative and scientifically based cannabis companies throughout North America. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.
On behalf of the board of directors of Lifestyle Delivery Systems Inc.
Brad Eckenweiler CEO & Director
FOR MORE INFORMATION, PLEASE CONTACT: firstname.lastname@example.org 1-866-347-5058
Lifestyle Delivery Systems Inc. Suite 820, 1130 W. Pender St.
Vancouver BC, V6E 4A4
T: (866) 347-5058 F: (604) 648-0517
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.